Vildagliptin compared to glimepiride in combination with metformin in patients with type 2 diabetes.

Trial Profile

Vildagliptin compared to glimepiride in combination with metformin in patients with type 2 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2015

At a glance

  • Drugs Vildagliptin (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 17 Sep 2014 Results of a post-hoc analysis of hypoglycaemia were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
    • 01 Sep 2010 2-year results published in Diabetes, Obesity and Metabolism.
    • 01 Feb 2009 Results published in Diabetes, Obesity and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top